▲ Peaking
Business
Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex’s $10 billion buy of Crinetics sparks intense focus on biotech M&A.
1 trends tracked about this subject — the full history, oldest to newest below.
Vertex’s $10 billion buy of Crinetics sparks intense focus on biotech M&A.